---
title: "礼来阿尔茨海默病药物最新研究：早期使用记能达可降低病情变重风险"
description: "在 2025 阿尔茨海默病协会国际会议上，礼来制药公布了新药记能达的三期临床研究长期扩展结果。研究显示，早期使用记能达可显著减缓阿尔茨海默病的进展，风险降低 27%。这强调了早筛早诊在治疗老年病中的重要性。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/251293514.md"
published_at: "2025-08-02T11:07:06.000Z"
---

# 礼来阿尔茨海默病药物最新研究：早期使用记能达可降低病情变重风险

> 在 2025 阿尔茨海默病协会国际会议上，礼来制药公布了新药记能达的三期临床研究长期扩展结果。研究显示，早期使用记能达可显著减缓阿尔茨海默病的进展，风险降低 27%。这强调了早筛早诊在治疗老年病中的重要性。

近日，“2025 阿尔茨海默病协会国际会议（AAIC）” 在加拿大多伦多召开，跨国制药巨头礼来在会上公布了去年获批新药——记能达（通用名：多奈单抗注射液）三期临床研究的长期扩展（LTE）结果。数据显示，相比阿尔茨海默病神经影像计划（ADNI）数据库中外部未经治疗的队列，接受记能达治疗的研究参与者的疾病进展显著减缓，获益在三年间持续增强。更值得注意的是，与延迟治疗组相比，早期使用记能达的研究参与者，其疾病进展至下一阶段的风险显著降低 27%，这意味着早筛早诊仍是破解这一老年病治疗困局的关键。（每经）

### Related Stocks

- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026 | Eli Lilly's stock is surging due to AI deals and a favorable drug pricing agreement. The healthcare sector, particularly | [Link](https://longbridge.com/zh-CN/news/267579204.md) |
| Eli Lilly joins a very exclusive club | Eli Lilly becomes the eleventh company to surpass $1 trillion in market capitalization, marking a milestone for healthca | [Link](https://longbridge.com/zh-CN/news/267672421.md) |
| Did Analyst Upgrades and Metal Price Tailwinds Just Shift Coeur Mining's (CDE) Investment Narrative? | Recent analyst upgrades for Coeur Mining, alongside rising gold and silver prices, have shifted focus on the company's c | [Link](https://longbridge.com/zh-CN/news/275995095.md) |
| A Goldman Sachs partner in technology shares the skills young job seekers need in the AI workplace | A Goldman Sachs partner in technology shares the skills young job seekers need in the AI workplace | [Link](https://longbridge.com/zh-CN/news/275976341.md) |
| Aberdeen Group plc Has $144.09 Million Position in Arista Networks, Inc. $ANET | Aberdeen Group plc increased its stake in Arista Networks, Inc. by 1.4% in Q3, owning 1,005,027 shares valued at $144.09 | [Link](https://longbridge.com/zh-CN/news/275999141.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。